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ABSTRACT
A major outcome of the canonical Wnt/b-catenin-
signalling pathway is the transcriptional activation
of a specific set of target genes. A typical feature
of the transcriptional response induced by Wnt
signalling is the involvement of Tcf/Lef factors that
function in the nucleus as the principal mediators of
signalling. Vertebrate Tcf/Lef proteins perform two
well-characterized functions: in association with
b-catenin they activate gene expression, and in the
absence of Wnt ligands they bind TLE/Groucho pro-
teins to act as transcriptional repressors. Although
the general characteristics of Tcf/Lef factors are
well understood, the mechanisms that control their
specific roles in various cellular backgrounds are
much less defined. In this report we reveal that the
evolutionary conserved Dazap2 protein functions as
a TCF-4 interacting partner. We demonstrate that a
short region proximal to the TCF-4 HMG box
mediates the interaction and that all Tcf/Lef family
members associate with Dazap2. Interestingly,
knockdown of Dazap2 not only reduced the activity
of Wnt signalling as measured by Tcf/b-catenin
reporters but additionally altered the expression of
Wnt-signalling target genes. Finally, chromatin
immunoprecipitation studies indicate that Dazap2
modulates the affinity of TCF-4 for its DNA-
recognition motif.
INTRODUCTION
The Wnt-signalling pathway is essential during diﬀerent
developmental processes for determining cell fate. In
addition, aberrant activation of this pathway has been
implicated in cellular transformation and cancer [see
some recent reviews (1–3)]. Transcription factors of the
Tcf/Lef family are important downstream eﬀectors of
the so-called canonical Wnt/b-catenin-signalling pathway.
In vertebrates the family consists of four members: Tcf-1,
Tcf-3, Tcf-4 and Lef-1 (4). All vertebrate Tcf/Lef proteins
(further referred to as Tcfs) contain virtually identical
DNA-binding domains, a high mobility group (HMG)
box, and a highly conserved b-catenin-interacting region.
In the absence of the Wnt signal, Tcf/Lef factors interact
with Transducin-like enhancer of split (TLE)/Groucho co-
repressors to mediate the transcriptional repression of Tcf-
bound genes (5–7). Alternatively, upon initiation of Wnt
signalling the constitutive degradation of b-catenin is
inhibited allowing this protein to accumulate both in the
cytoplasm and nucleus, with the nuclear form able to dis-
place TLE/Groucho co-repressors from Tcfs (8). Since
b-catenin contains a strong transactivation domain, Tcf/
b-catenin heterocomplexes function as transcriptional
activators of speciﬁc Wnt-responsive genes such as c-myc
(9), Cyclin D1 (10,11), Axin2 (12) and CD44 (13). For a
more comprehensive survey on Wnt signalling, please
refer to the Wnt signalling home page at http://www.
stanford.edu/%7ernusse/wntwindow.html.
Although the general function of Tcfs as transcriptional
repressors or co-activators is well understood, their spe-
ciﬁc roles in Wnt signalling or cell physiology are much
less deﬁned. Besides b-catenin and TLE/Groucho
co-repressors several other proteins associate with the
HMG box of Tcfs. Such factors include proteins contain-
ing the I-mfa domain that mask the DNA-interacting
region of Tcf-3, thereby preventing Tcf-3/b-catenin het-
erodimers from activating transcription (14). Likewise,
RUNX3 forms a ternary complex with b-catenin and
Tcfs to attenuate the transactivation potential of Tcf/
b-catenin complexes by decreasing their DNA-binding
activity (15).
Expression of mouse Tcf/Lef genes during embryogen-
esis and in adult tissues often overlaps. Nevertheless,
gene-targeting experiments have demonstrated that
individual Tcf members control their own cell biological
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out evolution the functions originally executed by a single
Tcf polypeptide have been distributed in more complex
organisms among several family members. A plausible
explanation for the functional diversity among Tcfs
would be their selective interaction with distinct partners
as the amino-acid sequences outside the highly conserved
DNA- and b-catenin-binding domains are less homolo-
gous. Indeed, it has been reported that LEF-1 activates
some promoters together with ALY, a nuclear protein that
speciﬁcally binds LEF-1 and AML-1 (20). Additionally,
LEF-1 cooperates with the Microphthalmia-associated
transcription factor (MITF) to activate the expression of
melanocyte-speciﬁc genes (21). Interestingly, although the
activity of LEF-1 is suppressed by association with PIASy
(a nuclear matrix-associated SUMO E3 ligase), this inter-
action results in increased TCF-4-regulated transcription
(22,23). Two Tcf/Lef family members, Tcf-3 and Tcf-4,
contain binding motifs for C-terminal-binding proteins
(CtBPs) at their C-termini (24–26). As CtBPs operate as
short-distance transcriptional repressors, interaction with
such factors strengthens the repressive potential of these
Tcfs in the absence of Wnt signalling (27). Besides CtBP,
TCF-4 also binds the Hypermethylated in cancer 1 (HIC1)
tumour suppressor. This interaction leads to the recruit-
ment of TCF-4 into nuclear ‘speckles’ called HIC1 bodies.
Upon association with HIC1, TCF-4 is unable to bind
Wnt-responsive gene promoters. Thus, HIC1 functions
as a nuclear TCF-4-speciﬁc Wnt pathway inhibitor (27).
Finally, to add another layer of complexity to the regula-
tion of Wnt target genes it has also been demonstrated
that alternative promoters and/or alternative splicing of
Tcf/Lef mRNAs occurs (28,29). A mechanism by which
distinct Lef/Tcf isoforms may acquire individual proper-
ties is illustrated by their interaction with Hic-5 (hydrogen
peroxide-induced clone 5). Hic-5 has been shown to bind a
highly conserved and alternatively spliced exon of Lef/Tcf
proteins and this results in the formation of a Lef/Tcf
subtype-speciﬁc repressive complex that prevents target
gene activation (30).
Mammalian Dazap2, also known as Proline codon-rich
transcript, brain expressed (Prtb), was originally isolated
in a mouse gene trap screen as a transcript expressed in the
inner ear (31). This gene encodes a small 17kDa protein
that is highly conserved throughout evolution. The protein
does not share signiﬁcant sequence homology with any
protein family and its most notable feature is a high con-
tent of prolines (17%) and several potential Src homology
2 (SH2)- and SH3-binding motifs (32). The Dazap2 gene is
broadly expressed during mouse embryonic development
and in adult mouse and human tissues (31,33–35).
Interestingly, Dazap2 mRNA and protein are frequently
down-regulated in multiple myeloma patients (36) whilst
Dazap2 mRNA is known to increase in adhering mouse
osteoblasts or in rat astrocytes grown in high ammonia or
hypo-osmotic conditions (37). In humans, Dazap2 inter-
acts with RNA-binding testes-speciﬁc proteins DAZ and
DAZL1 (35). In addition, Dazap2 also binds the Sox6
transcription factor to regulate L-type Ca
++ channel a1c
expression during cardiac myocyte development (33).
Recently, Kim and colleagues (38) described the
interaction of Dazap2 with the Eukaryotic initiation
factor 4G (eIF4G) which is essential for the formation
of discrete cytoplasmic foci, named stress granules
(SGs). SGs are formed upon translation inhibition and
contain translation initiation factors and 40S ribosomal
subunits (34,38). Finally, the protein level of Dazap2 is
regulated by its interaction with NEDD4, an E3 ubiquitin
ligase (39). Taken together, the aforementioned data indi-
cate that Dazap2 functions in diverse roles in cell biology
and physiology.
In this study we have used a yeast two-hybrid screen to
identify Dazap2 as a TCF-4 interacting partner. Further-
more, we show that a short region proximal to the TCF-4
HMG box mediates this interaction. Interestingly,
although this region is only partially conserved among
Tcfs, all Tcf/Lef family members associate with Dazap2
in mammalian cells. Upon interaction with TCF-4 the
subcellular distribution of Dazap2 is dramatically shifted
from the cytoplasm into the nucleus. Upon knockdown of
Dazap2a reduction in the activity of Tcf/b-catenin repor-
ters was observed along with the expression of several
Wnt-signalling target genes. Chromatin immunoprecipita-
tion experiments performed in cells with down-regulated
Dazap2 expression revealed a remarkable decrease in
TCF-4 binding to Tcf-responsive elements in the promo-
ters of genes tested. We propose that Dazap2 modulates
the aﬃnity of Tcfs to their recognition motifs.
MATERIALS AND METHODS
Plasmid constructs
Constructs encoding proteins fused at the N-terminus to
EGFP were prepared using the pEGFP-C vector
(Clontech); plasmids encoding Myc-tagged proteins were
generated using the pK-Myc vector (26) and plasmids
expressing Flag-tagged polypeptides were constructed in
the vector pFlag-CMV-5a (Sigma). cDNAs encoding
human TCF-4 (GenBank accession number NM_
030756), human TCF-1 (NM_003202), and mouse Lef-1
(NM_010703) were described previously (26,40,41). Full-
length cDNA encoding human TCF-3 (NM_031283) was
purchased from Open Biosystems whilst the cDNA encod-
ing human -catenin (NM_205081) was kindly provided
by B. Vogelstein (The Johns Hopkins Kimmel Cancer
Center); cDNA encoding the full-length human
DAZAP2 protein (NP_055579) was cloned by RT–PCR
using template mRNA isolated from DLD-1 cells. PCR
ampliﬁcation steps were performed with Phusion High-
Fidelity DNA Polymerase (Finnzymes). Mouse cDNA
encoding Wnt-1 [a gift from M.van Dijk (University
Hospital Utrecht)] was subcloned into the mammalian
expression vector pXJ41 (kindly provided by L. Andera,
IMG, Prague, Czech Republic). Mouse cDNA encoding
Grg4 [a TLE/Groucho repressor (NM_011600)] was
kindly provided by Z. Kozmik (IMG). Human TAB1
(U49928), mouse Tak1 (D76446) and mouse Nlk
(NM_008702) cDNAs were obtained from T. Ishitani
(Nagoya University). PCR-derived constructs were veri-
ﬁed by sequencing; details of plasmid constructs are
available on request.
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The cDNA encoding the N-terminal part of TCF-4
lacking the b-catenin-interacting domain [amino acids
(aa) 31–333] was subcloned into the vector pGBKT7
(Clontech) and introduced into yeast AH109 cells by the
standard lithium acetate transformation protocol.
Expression of the TCF-4 fragment and GAL-4 DNA-
binding domain (DBD) bait protein was tested in cell
lysates by immunoblotting using anti-Myc and anti-
TCF-4 monoclonal antibodies. A pre-transformed mouse
17-day embryo Matchmaker cDNA library ampliﬁed in
the yeast strain Y187 (Clontech) was used for the screen
according to the manufacturer‘s instructions. The ‘library’
and ‘bait’ cells were ﬁrst mated in liquid cultures before
subsequent plating on selective agar plates. After incuba-
tion at 30 C for 7–10 days, clones of growing cells were
picked and streaked onto fresh selective plates and sub-
jected to b-galactosidase ﬁlter lift assays. Plasmids isolated
from positive clones were transformed into the yeast strain
Y187 and their speciﬁcity tested by mini-mating with
AH109 yeast cells that expressed the GAL-4 DBD or
GAL-4 DBD-Lamin fusion proteins as bait. Clones that
speciﬁcally interacted with the GAL-4 DBD-TCF-4 bait
were sequenced. For the interaction domain mapping
experiment cDNAs encoding corresponding fragments of
TCF-4 (see legend to Figure 1 for details) were subcloned
into the pGBKT7 vector and the resulting constructs were
transformed into AH109 yeast cells. Individual yeast
clones were mated with Y187 cells containing the
Dazap2 prey and the growth of diploid yeast was tested
on agar plates under selective conditions.
Cell lines, transfections, retrovirus production and infection
Human embryonic kidney (HEK) 293, human HeLa,
DLD-1 and U2OS cells and mouse Wnt3a-producing
L cells were purchased from ATCC. Mouse C57MG
cells were kindly provided by R. Nusse and K. Willert
(Stanford University). HEK 293 FT cells used for produc-
tion of retroviral stocks were obtained from Invitrogen.
pSuperTOPFLASH HEK 293 (STF 293) cells containing
the integrated variant of the Wnt/b-catenin-responsive
luciferase reporter pSuperTOPFLASH (42) were a kind
gift from Q. Xu and J. Nathans (Johns Hopkins
University). Cell lines were maintained in Dulbecco’s
modiﬁed Eagle’s medium (DMEM) supplemented with
10% fetal bovine serum (Hyclone) and antibiotics. Cells
in cultures were regularly checked for the presence of
mycoplasma and only mycoplasma-free cells were used
in experiments. Transfections of human cells were per-
formed using the Lipofectamine RNAiMAX [small inhib-
itory RNAs (siRNA) transfections] or Lipofectamine 2000
reagent (plasmid or combined plasmid and siRNAs trans-
fections). Both reagents were purchased from Invitrogen.
C57MG cells were transfected using Fugene HD (Roche).
Retroviral stocks were produced as described previously
(26). Lentiviral stocks were prepared using the Trans-
Lentiviral Packaging System (Open Biosystems) according
to the manufacturer’s protocol. Retroviral (or lentiviral)
infections have been described previously (26); puromycin
(Alexis; ﬁnal concentration 5mg/ml) resistant cells were
selected without subcloning for 10 days and used in sub-
sequent experiments.
GST interaction assays
Constructs expressing Glutathione S-transferase (GST)-
TCF-4 fusion proteins were prepared using the pET-42b
vector (Novagen). GST-TCF-4 (full-length), GST-TCF-
4-N-term (aa 1–333), GST-TCF-C-term (aa 333–596),
GST-TCF-4 (aa 1–214), GST-TCF-4 (aa 1–228), GST-
TCF-4 (aa 214–310), GST-TCF-4 (aa 228–310) and
GST-b-catenin (full-length) fusion proteins were expressed
in the BL21 (DE3) strain of Escherichia coli. The mouse
Dazap2 and human TCF-4 proteins were produced
in vitro using the Quick TNT Coupled Reticulocyte
System (Promega). A detailed protocol describing GST
pull-down assays was reported previously (26).
Antibodies, co-immunoprecipitation and western blotting
Antiserum to Dazap2 was produced by immunization of
rabbits or hens with a bacterially expressed mouse full-
length polypeptide. An anti-b-catenin rabbit polyclonal
antibody was produced by immunization with a bacte-
rially expressed C-terminal fragment (aa 585–781) derived
from the human polypeptide; an anti-b-catenin mouse
monoclonal antibody was prepared in collaboration with
Exbio Praha (Czech Republic) using standard techniques
from the splenocytes of mice immunized with a bacterially
produced b-catenin fragment. The anti-TCF-4 monoclo-
nal and anti-TCF-4 and anti-EGFP rabbit polyclonal
antibodies were reported previously (27). The following
commercially available mouse monoclonal antibodies
were used: anti-Myc 9E10 (Roche), anti-Flag M2
(Sigma), anti-Flag (Exbio), anti-a-tubulin TU-01
(Exbio). A detailed protocol describing the immunoblot-
ting procedure can be found in the Supplementary Data.
Immunoﬂuorescent microscopy
For immunoﬂuorescence studies, Dazap2 polyclonal anti-
bodies were puriﬁed by aﬃnity chromatography using the
GST-Dazap2 antigen coupled to glutathione Sepharose
4B (Amersham Pharmacia Biotech) (43). The puriﬁed
antibodies were subsequently stored at 4 C in PBS supple-
mented with 1% BSA [(w/v), Sigma, molecular biology
grade]. Monoclonal antibodies were used as hybridoma
cell culture supernatants without dilution. Cells grown
on coverslips were ﬁxed (when cells were transfected
prior to staining, the ﬁxation was performed 18h after
transfection) in cold methanol ( 20 C, 5min) followed
by a brief incubation in acetone ( 20 C, 30s).
Alternatively, ﬁxation was performed for 10min at room
temperature using a 4% (v/v) solution of paraformalde-
hyde (Electron Microscopy Sciences) diluted in PBS
before cells were subsequently permeabilized with 0.2%
(v/v) Triton X-100 (Sigma; room temperature, 15min)
diluted in PBS. After washing with PBS, cells were pre-
incubated in 1% BSA (Fraction V; Sigma) for 20min
at room temperature. The cells were then stained with
primary GST-Dazap2-puriﬁed polyclonal antibodies
(5mg/ml in PBS) or with an anti-TCF-4 monoclonal anti-
body (undiluted hybridoma culture supernatant; room
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times with PBS, and consecutively incubated with a rele-
vant ﬂuorescently labelled secondary antibody. The
ALEXA 488 dye conjugated to goat anti-chicken or
goat anti-rabbit antibodies and ALEXA 594 conjugated
to a goat anti-mouse antibody (dilution 1:500; Molecular
Probes) were used. To pre-block the Dazap2 antibody,
antigen-puriﬁed antibodies (20mg/ml) were incubated
with the bacterially expressed Dazap2 or EGFP (negative
control) proteins (overnight at 4 C; the concentration of
recombinant protein in each sample was 50mg/ml), before
being diluted in PBS (ﬁnal concentration 5mg of the anti-
body per ml) and used for staining. Finally, the samples
were washed three times in PBS, incubated with DAPI
nuclear stain (Molecular Probes; 1min, room tempera-
ture, ﬁnal concentration 1mM), washed and mounted in
MOWIOL (Calbiochem). Immunoﬂuorescence was visua-
lized using a confocal laser scanning microscope (TCS
SP5; Leica). The system was carefully tested for overlaps
between individual optical channels and the microscopic
images were taken separately for each ﬂuorescence chan-
nel using the sequential scanning mode.
RNA puriﬁcation and real-time quantitative
RT–PCR (qRT–PCR)
Standard procedures were used for RNA puriﬁcation and
reverse transcription. Brieﬂy, total RNAs were isolated
from cells using the Trizol reagent (Invitrogen); random
or oligo dT-primed cDNA was prepared in a 20ml reaction
from 1mg of total RNA using Superscript II RNAseH
 
reverse transcriptase (Invitrogen). cDNAs were produced
from at least two independent RNA isolations and the
PCR reactions were performed in triplicate for each
primer set. Two percent of the resulting cDNA was used
for one quantitative PCR reaction. Control reactions
(containing corresponding aliquots from cDNA synthesis
reactions that were performed without reverse transcrip-
tase; minus RT controls) were run in parallel duplicates.
PCR reactions were run using the LightCycler 480 Real-
Time PCR System (Roche). Typically, a 5ml reaction mix-
ture contained 2.5ml of LightCycler 480 SYBR Green I
Master mix (Roche), 0.5ml of primers (ﬁnal concentration
0.5mM) and cDNA diluted in 2ml of deionized water.
Crossing-threshold (CT) values were calculated by
LightCycler 480 Software (Roche) using the second-
derivative maximum algorithm. The speciﬁcity of each
PCR product was analysed using the in-built melting
curve analysis tool for each DNA product identiﬁed; addi-
tionally, some selected PCR products were veriﬁed by
sequencing. All primers were calculated using Primer 3
computer services at http://frodo.wi.mit.edu/. Two house-
keeping genes, -actin and ubiquitin C (Ubc) were used as
internal control genes to standardize the quality of diﬀer-
ent cDNA preparations (44). Primer sequences are listed
in Supplementary Data.
Wnt3a puriﬁcation
Recombinant mouse Wnt3a ligand was isolated from
the culture medium of Wnt3a-producing L cells accord-
ing to a detailed protocol published on the Internet
(http://www.stanford.edu/%7ernusse/assays/W3aPurif.
htm). The activity of individual batches of puriﬁed Wnt3a
protein were tested using Wnt3a-stimulated and control
(Wnt3a storage buﬀer added only) STF 293 cells and luci-
ferase assays.
Knockdown of Dazap2
For gene knockdowns of human DAZAP2, four duplex
siRNAs were purchased from Dharmacon. The target
sequences (on the plus DNA strand) were as follows: #1
50-GGA GCC AAC GUC CUC GUA A-30,# 25 0-CAC
CAU GUC AGC CGC AUU U-30,# 35 0-UCA GAG
CUC UAU CGU CCG A-30,# 45 0-CUU CAU GGG
UGG UUC AGA U-30. Control EGFP siRNA
(Dharmacon) target sequence was: 50-GCG ACG TAA
ACG GCC ACA AGT TC-30. Cells transfected with
duplex siRNAs at a concentration of 30nM were grown
for 24–72h before further analysis. To generate a stable
knockdown of Dazap2 in mouse C57MG cells, the cells
were transduced with retroviruses (purchased from Open
Biosystems) that express Dazap2 shRNA (shRNA
#1 code: TRCN0000085966, shRNA #2 code:
TRCN0000085965). Non-silencing lentiviral shRNAmir
(pGIPZ; Open Biosystems) were used as a control. The
constructs were packaged and transduced into the target
cells as described by the manufacturer. The cells were
selected without subcloning using appropriate antibiotics
before they were used for further analysis.
Reporter gene assays and Wnt stimulation
To assay TCF-mediated transcription, ﬁreﬂy luciferase
pTOPFLASH and pFOPFLASH reporters containing
either three copies of the optimal Tcf motif GATCAAA
GG or three copies of a mutant motif GGCCAAAGG,
respectively were used (45). Additionally, Cyclin D1 repor-
ter constructs containing one copy of the Tcf-interacting
motif (designated 163CD1LUC) or its mutated variant
(163mtLefCD1LUC) (10) (a gift from A. Ben-Ze’ev, The
Weizmann Institute of Science) and the Axin2 promoter
reporter (46) (a gift from F. Costantini, Columbia
University Medical Center) were used. Reporter gene
assays were performed as described previously (26).
Brieﬂy, cells were seeded into 24-well plates ( 10
5cells
per well, depending on the cell type) and transfected 2h
later with a Lipofectamine mixture containing 100ng
Renilla pRL-SV40 plasmid (Promega) as an internal con-
trol, 500ng luciferase reporter plasmid, and up to 1mgo f
the particular expression vector. The total amount of
DNA was kept constant by adding empty expression
vector where necessary. For transfection into STF 293
cells (containing an integrated TCF-dependent reporter
pSuperTOPFLASH) (42,47), a mixture that included
50ng Renilla plasmid and up to 1.5mg of a speciﬁc expres-
sion or stuﬀer vector was prepared. Two independent
systems were utilized to activate Wnt signalling: (i)
co-transfection of cells with a Wnt1-expressing plasmid.
Cells were analysed 24h post-transfection; (ii) stimulation
of cells with puriﬁed recombinant Wnt3a ligand. Cells
were transfected with corresponding constructs and 15h
post-transfection recombinant Wnt3a (only the vehicle
3010 Nucleic Acids Research, 2009,Vol.37, No. 9was used in control experiments) was added and the
cells cultured for additional 16h before their harvest
and lysis. The activity of ﬁreﬂy and Renilla luciferase in
cell lysates were determined using the Dual luciferase
system (Promega) and a single tube luminometer
Sirius (Berthold). All reporter gene assays were done in
triplicate. Reporter gene activities shown are average
values plus standard deviations calculated from at least
three independent experiments after normalization against
the activity of Renilla luciferase.
Chromatin immunoprecipitation (ChIP)
For ChIP experiments, STF 293 cells were grown in 10-cm
culture dishes and transfected either with siRNA #2 tar-
geting Dazap2 or control siRNA (non-silencing siRNA
set; Dharmacon). Two days later the cells were transferred
into 15-cm culture dishes and subsequently stimulated
with Wnt3a or Wnt3a storage buﬀer alone for 16h. The
cells were ﬁxed directly in the dishes using formaldehyde
[1% (v/v); Sigma] then harvested and subjected to ChIP
analysis according to Kirmizis (48). Usually, chromatin
isolated from cells grown in one 15-cm culture dish was
used for immunoprecipitation with one speciﬁc antibody.
Rabbit anti-Dazap2, TCF-4 and b-catenin polyclonal
antibodies were used for ChIP; the negative control
experiments were performed with a rabbit anti-EGFP
polyclonal antibody. The amount of precipitated DNA
was analysed using the LightCycler 480 Real-Time PCR
System (Roche) in an analogous manner to real-time
qRT–PCR. Half a percent of decrosslinked and puriﬁed
(by phenol extraction) input chromatin (chromatin that
was not subjected to ChIP) was analysed in control PCR
reactions. The primers used for the PCR ampliﬁcation are
listed in the Supplementary Data.
RESULTS
Dazap2, a small evolutionary conserved protein,
interacts with the TCF-4N-terminus
It is well known that the function of the nuclear eﬀectors
of Wnt signalling, the Tcf/Lef transcription factors, can be
modulated by various interacting partners. As such, we
decided to perform a yeast two-hybrid screen (Y2H) to
search for novel TCF-interacting proteins. An N-terminal
part of human TCF-4 protein (aa 31–333) was used as
bait. This truncated protein lacks its very N-terminus
that encodes the main b-catenin-interacting domain
(8,49) as well as the C-terminal DNA-binding HMG box
(Figure 1A). From a cDNA library collected from a Day
17 mouse embryo we obtained seven yeast colonies (out of
 5 10
7 diploid yeast cells) growing in selective broths.
Of these clones only one encoded a protein that speciﬁ-
cally interacted with the TCF-4 bait and not the Gal-4
DNA-binding domain (DBD) alone, Gal-4 DBD-Lamin
and Gal-4 DBD-p53 fusion proteins or with the
C-terminal part of TCF-4 used as bait in our previous
study (26) (Figure 1A and data not shown). The result-
ing plasmid DNA isolated from the yeast cells encoded a
full-length 168 aa polypeptide described previously as
Proline codon-rich transcript, brain expressed (Prtb) or
DAZ-associated protein 2 (Dazap2) (31,35). Although
Dazap2 does not share signiﬁcant homology with
any known protein family, Dazap2 orthologues isolated
from various species display remarkable sequence similar-
ity (there is only one amino acid change between human
and mouse proteins), especially within the C-terminal half
(Figure 1B and Supplementary Figure 1). To determine
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Figure 1. Interaction between Dazap2 and TCF-4 in a yeast two-
hybrid screen. (A) Deletion mutants of human TCF-4 (schematically
represented on the right as thick black lines) were tested in an Y2H
mini-mating assay for interaction with full-length mouse Dazap2. The
left panel shows the growth of clones of yeast cells on selective agar
plates. The yeast cells contain plasmids as indicated above and express
TCF-4 deletion mutants that are depicted on the right. None of the
TCF-4 proteins binds to the separate GAL4 activation domain (AD)
encoded by ‘empty’ library vector pACT2 or to the fusion protein
GAL4 AD-SV40T large antigen (pSV40T). b-cat, b-catenin interaction
domain; TLE/Groucho, TLE/Groucho-binding domain; CtBP, CtBP-
binding sites; HMG, DNA-binding domain. (B) Amino-acid compari-
son of human, sea squirt (Ciona) and red ﬂour beetle (Tribolium)
Dazap2. Protein sequences were aligned by the ClustalV program.
The amino-acid diﬀerences are boxed. GenBank accession numbers:
Homo sapiens, NP_055579; Tribolium castaneum, XP_973572; Ciona
intestinalis, NM_001032667. (C) The Dazap2 gene is broadly expressed
in tissues and cell lines. Results of qRT–PCR analyses performed with
Dazap2-speciﬁc primers on cDNA generated from adult mouse tissues,
mouse mammary epithelium C57MG cells, human medulloblastoma
DAOY, human embryonic kidney HEK 293, human adenocarcinoma
DLD-1 and human lymphoma U-937 cells. The reactions were per-
formed in triplicate. The results shown are from one representative
experiment from a total of two. The expression levels of Dazap2
mRNA in the indicated tissues or cell lines are presented as average
CT values and the corresponding standard deviations (SD) after nor-
malization to the levels of -actin cDNA.
Nucleic Acids Research,2009, Vol.37, No. 9 3011the expression pattern of Dazap2 mRNA in adult mouse
tissues and several diﬀerent cell lines we performed quanti-
tative real-time RT–PCR analysis (qRT–PCR), which
revealed virtually ubiquitous expression (Figure 1C). We
further delineated the minimal region in TCF-4 required
for association with Dazap2. We generated several
deletions in the TCF-4 bait used for the primary screen
and tested their ability to interact with full-length
Dazap2 via Y2H. As shown in Figure 1A, truncated bait
containing aa 80–251 was able to bind Dazap2, however,
a protein spanning aa 1–214 could not. Taken together,
these results reveal that the relatively short sequence
in TCF-4 spanning aa 214–251 is essential for the
interaction.
All Tcf/Lef family members associate with Dazap2 in
mammalian cells
Direct binding between Dazap2 and TCF-4 was evaluated
in vitro by pull-down assays that utilized bacterially
expressed GST-tagged TCF-4 and in vitro translated
Dazap2. Dazap2 associated both with full-length GST-
TCF-4 and with the truncated TCF-4 N-terminal frag-
ment. No interaction was detected between Dazap2 and
GST alone or with the C-terminal part of TCF-4 (TCF-
4-C-term) that encompassed the DNA-binding HMG box
domain (Figure 2A and data not shown). Furthermore, we
performed a detailed mapping of the putative interaction
domains in both proteins using pull-down assays.
In agreement with Y2H the Dazap2-binding region
was mapped to aa 214–228 in the TCF-4N-terminus
(Figure 2A). On the other hand, any truncation of
Dazap2 abolished its association with TCF-4 (Supplemen-
tary Figure 2 and data not shown), indicating that non-
adjacent parts of the Dazap2 polypeptide participate in
the interaction interface. The interaction of Dazap2 with
TCF-4 was further conﬁrmed in mammalian cells using
co-immunoprecipitations. Experiments involving HEK
293 cells double-transfected with constructs expressing
Dazap2-Flag and TCF-4-Myc demonstrated that Flag-
tagged Dazap2 could be co-isolated with Myc-tagged
TCF-4 when an anti-Myc monoclonal antibody was
used for precipitation; conversely, Myc-tagged TCF-4
was present in the anti-Flag precipitates (Figure 2B).
The interaction of these two proteins is speciﬁc since par-
allel single-transfection assays did not reveal any binding
of Dazap2 and TCF-4 to the anti-Myc- or anti-Flag-tag
antibodies, respectively (Figure 2B). In addition, we ana-
lysed the ability of endogenous TCF-4 and Dazap2 to
interact by performing co-immunoprecipitation assays
with rabbit polyclonal antibodies raised against these
polypeptides. Analysis of a variety of cell types (DLD-1,
HEK 293, C57MG) by co-immunoprecipitation using the
anti-Dazap2 or anti-TCF-4 antibodies conﬁrmed our ear-
lier observations and demonstrated that endogenous
Dazap2 and TCF-4 do associate. Negative control reac-
tions using an anti-EGFP rabbit polyclonal antibody
failed to pull down any proteins again conﬁrming that
the interaction is speciﬁc (Figure 2C and data not
shown). The human colon adenocarcinoma cell line,
DLD-1 harbours a mutation in the tumour suppressor
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Figure 2. Association between Dazap2 and TCF-4 in vitro and in
mammalian cells. (A) Interaction of Dazap2 with TCF-4 in GST
pull-down assays. The top panel represents a schematic diagram of
the TCF-4 proteins used in the in vitro pull-down assays. The bottom
panel displays the pull-down assay results between the diﬀerent bacte-
rially expressed GST fusion TCF-4 proteins and in vitro translated
[
35S]-labelled Dazap2. Ten percent of the total reaction was loaded in
the lane denoted ‘Input’. Under the autoradiograph is a Coomassie
Blue-stained gel that shows the amount of GST-tagged TCF-4 proteins
used in the experiment. The putative intact forms of the recombinant
proteins are labelled by asterisks; the faster migrating bands result from
a partial degradation of the corresponding GST fusion proteins.
Molecular weight markers in kDa are indicated on the left. (B)
Co-immunoprecipitation of FLAG-tagged Dazap2 and MYC-tagged
TCF-4. Cell lysates prepared from HEK 293 cells transfected with
constructs as indicated were precipitated using anti-MYC and
anti-FLAG monoclonal antibodies. The asterisks indicate the light
chains of immunoglobulins used in the experiments. (C) Endogenous
complexes of Dazap2, TCF-4 and b-catenin in human cells. Lysates
prepared from DLD-1 cells were subjected to immunoprecipitation
with anti-Dazap2, anti-TCF-4, anti-b-catenin or anti-EGFP (Control
Ig) rabbit polyclonal antibodies. Blots were probed by either
anti-TCF-4, anti-b-catenin mouse monoclonal or anti-Dazap2 chicken
polyclonal antibodies. In lanes denoted ‘Input’, 10% of the total
lysate used for one immunoprecipitation was loaded; IP, immunopre-
cipitation; IB, immunoblotting.
3012 Nucleic Acids Research, 2009,Vol.37, No. 9APC that results in the accumulation of nuclear TCF-4/
b-catenin complexes. Interestingly, Dazap2 was present in
the precipitates obtained by incubating DLD-1 cell lysates
with an anti-b-catenin antibody and similarly, b-catenin
was isolated using an anti-Dazap2 antibody (Figure 2C).
Since we did not detect any association between Dazap2
and b-catenin in GST pull-down assays (Supplementary
Figure 3) we conclude that these proteins do not interact
directly but are instead brought to one heterocomplex via
association with their common partner, the TCF-4 factor.
We also noted that the endogenous TCF-4 protein
extracted from various mammalian cells migrates in the
denaturing gels as a double band representing polypep-
tides of the apparent molecular weight 65 and 85kDa,
respectively (Figures 2C, 5A, 6A and data not shown).
Interestingly, both these bands showed immunoreactivity
with various monoclonal antibodies recognizing diﬀerent
epitopes in TCF-4 (data not shown). Moreover, ectopic
expression of TCF-4 generated two diﬀerent protein
forms similar to their endogenously produced counter-
parts (Figure 2B and Supplementary Figure 5). As the
expression of the both putative TCF-4 proteins was spe-
ciﬁcally down-regulated by TCF-4 shRNA (Supplemen-
tary Figure 4) and the predicted Mw of TCF-4 is
65.3kDa, we concluded that the slower migrating and
mostly more prominent band represents the TFC-4 poly-
peptide, possibly modiﬁed by sumoylation (23).
To visualize the subcellular distribution of endogenous
DAZAP2 protein we selected the human lymphoma
U-937 cell line as it exhibits a relatively high level of
DAZAP2 mRNA expression (Figure 1C). Analysis of
Dazap2-stained cells by confocal microscopy revealed a
predominantly cytoplasmic distribution with some addi-
tional nuclear staining (diﬀuse or in distinct dots or
‘puncta’) (Figure 3A). The staining of putative Dazap2
protein was speciﬁc as both polyclonal antisera showed
a virtually identical subcellular distribution. Moreover,
the observed reactivity was completely abolished by pre-
incubation of the primary antibodies with Dazap2 (and
not with control EGFP) recombinant protein (Figure 3A
and data not shown). Finally, we tested the co-localization
of ectopically expressed TCF-4 and Dazap2 (either EGFP-
or Myc-tagged) in HeLa cells. In single-transfected cells
expressing either TCF-4 or Dazap2, TCF-4 was clearly
nuclear whilst Dazap2 (visualized by either EGFP or
Myc antibodies) displayed a primarily cytoplasmic and
partly nuclear localization. When both proteins were
co-expressed, Dazap2 was sequestered to the nucleus in
a dose-dependent manner unlike the control EGFP-only
protein, which remained uniformly distributed between
the cytoplasm and nucleus irrespective of the presence or
absence of the TCF-4 factor (Figure 3B and data not
shown). Altogether, the data reported here indicate that
Dazap2 interacts directly with TCF-4 and that this inter-
action results in its subcellular redistribution to the
nucleus.
As the essential region in TCF-4 required for binding to
Dazap2 displays some sequence homology with the corre-
sponding sequences in other Tcf/Lef family members
(Figure 4A), we decided to further analyse whether
Dazap2 can interact with additional Tcf/Lef proteins.
Constructs expressing Myc-tagged TCF-1, -3, -4, Lef-1
and Flag-tagged Dazap2 were either single- or double-
transfected into HEK 293 cells and their ability to interact
was tested by co-immunoprecipitation using anti-Myc
or anti-Flag antibodies as described above. All TCF/Lef
proteins analysed were isolated from cell lysates con-
taining Flag-Dazap2 using the anti-Flag antibody.
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Figure 3. TCF-4 translocates Dazap2 into the nucleus.
(A) Endogenous Dazap2 protein shows a mostly cytoplasmic distribu-
tion in human cells. Laser scanning confocal micrographs of U-937
cells stained with an antigen-puriﬁed chicken anti-Dazap2 polyclonal
antibody. The merged images (c) and (f) were generated by an overlay
of endogenous Dazap2 captured in the green channel and the DAPI
nuclear stain captured in the blue channel. The ﬁrst row, labelled
‘Control’, shows the cells stained with the primary antibody pre-
blocked with Dazap2 recombinant protein as described in the
‘Materials and methods’ section; inset in (f) shows a magniﬁed image
as indicated. Bar, 10mm. (B) Nuclear co-localization of ectopically
expressed EGFP-Dazap2 and TCF-4 proteins. Laser scanning confocal
microscopy images of HeLa cells transfected with constructs (as indi-
cated on the left) and subsequently stained with the mouse anti-TCF-4
monoclonal antibody. The images (i, j, k, l) show cells transfected with
TCF-4 and EGFP-Dazap2 constructs at a ratio 0.25 (TCF-4) to 1
(EGFP-Dazap2); the images (m, n, o, p) were obtained at a ratio 1
to 1. The merged images (d, h, l, p) were generated by an overlay of the
corresponding images gained either in the green input channel detecting
EGFP-Dazap2, red input channel detecting TCF-4 or blue channel to
detect the DAPI nuclear stain. Inset in (h) shows a magniﬁed image as
indicated. Bar: 10mm.
Nucleic Acids Research,2009, Vol.37, No. 9 3013Reciprocally, Dazap2 was similarly pulled down from cells
co-expressing Myc-tagged TCF/Lef proteins with the anti-
Myc antibody (Figure 4B). In agreement with previous
results Dazap2 did not co-immunoprecipitate with the
C-terminal part of TCF-4 (TCF-4-C-term) lacking the
Dazap2-interaction domain (Figure 4B). Since the short
stretch of amino acids mediating the Dazap2 binding is in
close proximity to a region which is alternatively spliced
in most of Tcf/Lef family members (alternative splicing
involves exon IVa in Tcf-1, exon VI in Lef-1 and exon
VIII in Tcf-4) (50–52), we generated a TCF-4 variant lack-
ing exon VIII and tested its ability to bind Dazap2 in GST
pull-down and co-immunoprecipitation assays. As this
variant associated with Dazap2 to the same extent as the
non-spliced form (Supplementary Figure 5), the assays
further conﬁrmed the importance of the already deﬁned
interaction motif.
Dazap2 knockdown decreases Wnt/b-catenin-mediated
transcription
To examine whether Dazap2 overexpression has any eﬀect
on Wnt-mediated transcription we co-transfected a TCF/
b-catenin-responsive luciferase reporter, pTOPFLASH or
its mutated variant, pFOPFLASH into HEK 293 cells in
conjunction with a Dazap2 expression construct. The cells
were subsequently stimulated by recombinant Wnt3a and
the luciferase activities were determined from cell lysates.
The ectopic expression of Dazap2 displayed neither an
inhibitory nor stimulatory eﬀect on Wnt signalling.
Furthermore, analyses of Wnt-regulated transcription in
DLD-1 cells that should exhibit constitutive Wnt signal-
ling or U2OS cells that are activated by the Wnt3a ligand
were not aﬀected by Dazap2 overexpression (data not
shown). Finally, RNA interference (RNAi) was used to
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Figure 5. The activity of the Wnt/b-catenin-dependent reporters positively correlates with the amounts of Dazap2 in the cells. (A) HEK 293 cells
containing the integrated reporter pSuperTOPFLASH (STF 293 cells) were transfected with four diﬀerent Dazap2-speciﬁc siRNAs marked 1 to 4 or
with control siRNA (EGFP-speciﬁc) and the changes in the levels of Dazap2 mRNA or protein were tested 24h post transfection. The left panel
shows the results obtained by qRT–PCR analysis. The relative abundance of Dazap2 mRNA in Dazap2 siRNA- versus control siRNA-transfected
cells (the level of Dazap2 mRNA in control cells was set to 100%) was derived from the average CT values after normalizing to the levels of
-ACTIN cDNA. Data from two independent experiments performed in triplicate were combined in the graph. SDs (standard deviations) are shown
by error bars. The right panel shows western blots of whole cell extracts prepared from STF 293 cells treated with siRNAs as indicated. Blots were
probed with anti-Dazap2, anti-TCF-4 or anti-a-tubulin (as an internal control) antibodies. (B) Results of the reporter gene assays in human cells.
STF 293 and DLD-1 adenocarcinoma cells were transfected with Dazap2 or control siRNAs. To stimulate the integrated pSuperTOPFLASH in STF
293 cells the siRNA transfection mixtures additionally contained a Wnt1-expression construct; mixtures including an empty vector were used in
control transfections. DLD-1 cells were co-transfected with siRNA and the Tcf/b-catenin-responsive reporter pTOPFLASH or pFOPFLASH as a
negative control. After 24h, cells were harvested and luciferase (ﬁreﬂy) activities were determined in the lysates. The histograms represent mean
values of triplicate experiments with SDs. The reporter activity in unstimulated (empty vector) STF 293 cells was arbitrarily set to 1. For DLD-1 cells
the average luciferase light units per second (RLU/s) are given; the values were corrected for the eﬃciency of transfection using the internal control
Renilla luciferase expression plasmid. The results of one representative experiment from two in total are shown.
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Figure 4. Dazap2 interacts with all members of the Tcf/Lef family. (A) The region of TCF-4 required for interaction with Dazap2 as identiﬁed
by GST pull-down assays (aa 214–228) is partly conserved in other Tcf/Lef family members. The corresponding sequences of the human proteins
were aligned using the ClustalV program. Fully conserved amino-acid residues are boxed whilst amino-acid residues with similar biochemical
properties are underlined. GenBank accession numbers: TCF-4, NP_110383; TCF-3, NP_112573; LEF-1, NP_057353; TCF-1, NP_003193. (B)
Co-immunoprecipitation of Dazap2-FLAG and MYC-tagged TCF/LEF transcription factors in human HEK 293 cells transfected with various
Tcf expression constructs as indicated. Co-immunoprecipitation of TCF/LEF proteins using an anti-FLAG antibody is also shown. In the gel
denoted ‘Input’, 10% of total lysates was loaded. The asterisks indicate the heavy chains of immunoglobulins used in the experiments.
3014 Nucleic Acids Research, 2009,Vol.37, No. 9down-regulate the expression of Dazap2 and the resulting
Tcf/b-catenin-dependent transcription was analysed.
First, we utilized four distinct siRNA duplexes and
tested their eﬃciency towards Dazap2 mRNA using
qRT–PCR and western blotting. As shown in
Figure 5A, all four siRNAs reduced the levels of Dazap2
mRNA and protein to diﬀerent extents, with siRNA #1
and #2 showing the highest eﬃciency (as compared to the
control EGFP siRNA). Subsequently, we introduced by
lipofection the siRNAs into cells containing the genome-
integrated variant of the pTOPFLASH reporter, pSuper
TOPFLASH [the resultant cells were termed pSuper
TOPFLASH (STF) 293]. To stimulate Wnt signalling
the cells were co-transfected with a Wnt1 expression con-
struct. Twenty-four hours post-transfection the cells were
harvested, cell lysates prepared and luciferase activities
measured. In a parallel analogous experiment, DLD-1
cells were co-transfected with siRNA duplexes and a
DNA mixture containing the pTOPFLASH or
pFOPFLASH (negative control) reporter in addition to
a Renilla luciferase-expressing plasmid that acted as an
internal control. The next day cells were harvested and
processed as described for STF 293 cells. Surprisingly,
Tcf-driven transcription measured from the integrated or
ectopic reporter pTOPFLASH was substantially reduced
in the Dazap2 siRNA-treated cells. Of importance, the
extent of signalling reduction corresponded to the eﬃ-
ciency of the Dazap2 knockdown as documented for the
individual Dazap2-speciﬁc siRNAs (Figure 5B). Virtually
identical results were obtained with Wnt-stimulated U2OS
cells (data not shown). Furthermore, Dazap2 protein
knockdown also negatively aﬀected the transcription of
two additional well-deﬁned Tcf/b-catenin-dependent
reporter constructs that contained either a 5-kb promoter
region of the Axin2 (46) gene or a 163-nt long enhancer
element proximal to the transcription start of the Cyclin
D1 gene (10) (Figure 5B). Importantly, when a single Tcf/
Lef-binding site in the Cyclin D1 reporter was mutated,
the resulting plasmid (designated as LEF-Cyclin D1) not
only lost its responsiveness to Wnt signalling but its basal
expression did not change in cells treated with Dazap2 or
control siRNA (Figure 5B). To ensure the two Dazap2-
speciﬁc siRNAs used did not induce any non-speciﬁc ‘oﬀ-
target’ eﬀects, two lentiviral constructs containing shRNA
against mouse Dazap2 were purchased and introduced
into mouse mammary epithelium C57MG cells. Since
both shRNAs showed a similar eﬃciency to down-
regulate Dazap2 expression (Figure 6A) and the Wnt stim-
ulation had no eﬀect on Dazap2 expression (Figure 6A
and B), the polyclonal cell cultures were mixed and luci-
ferase reporter assays performed. As expected, the cells
with down-regulated Dazap2 displayed a decrease in
Wnt-stimulated transcription as compared to control
cells containing non-silencing shRNAs (generated in
parallel experiments) (Figure 6C). Therefore, these experi-
ments conﬁrm our previous results obtained from tran-
sient transfection assays performed in human cells.
To analyse whether Dazap2 knockdown has any eﬀect
on the transcription of endogenous Wnt-signalling tar-
get genes, C57MG cells expressing Dazap2 or control
shRNAs were stimulated with Wnt3a ligand and the
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Figure 6. Down-regulation of Dazap2 reduces the responsiveness of
C57MG cells to Wnt3a stimulation. (A) The top panel shows a series
of western blots from whole cell extracts prepared from mammary
gland epithelium C57MG cells transduced with retroviral vectors
expressing either a non-silencing control shRNA or two diﬀerent
Dazap2 shRNAs. Prior to harvesting, cells were stimulated with
Wnt3a ligand for 16h. The blots were probed with antibodies as indi-
cated. The bottom panel shows the western blot of whole cell extracts
prepared from non-silencing control shRNA-treated cells incubated
with Wnt3a or vehicle for 16h. (B) The relative abundance of
Dazap2 mRNA in control or Dazap2 shRNAs-expressing (a mixed cul-
ture of cells containing Dazap2 shRNA 1 and 2 was used) cells as
measured by qRT–PCR. The cells were cultured without activation
or stimulated with Wnt3a for 16h. The expression of the Dazap2
gene is indicated by average CT values obtained by qRT–PCR assay
on the corresponding mRNA after normalization to the levels of
-actin cDNA. (C) The left panel depicts control or Dazap2 shRNA
#1 and #2-producing C57MG cells that were transfected with the indi-
cated reporters. Twenty-four hours post-transfection, cells were either
stimulated with Wnt3a ligand or grown without stimulation. After
additional 16h, the cells were harvested and luciferase activities were
determined in lysates. These activities were corrected for the eﬃciency
of transfection by determining the luciferase/Renilla ratio. Values in
unstimulated cells were arbitrarily set to 1. Transfections were done
in triplicates and the results from one experiment out of two in total
are presented with SDs. The right panel shows cDNAs prepared from
Wnt3a-treated or control cells expressing non-silencing or Dazap2
shRNAs analysed by qRT–PCR. The relative abundance of the indi-
cated mRNAs in given cells (the levels of the tested mRNAs in unsti-
mulated cells was set to 1) was derived from the average CT values
after normalizing to the levels of -actin cDNA. Data shown are from
one representative experiment from a total of two.
Nucleic Acids Research,2009, Vol.37, No. 9 3015expression of several putative Tcf/b-catenin targets was
assessed by qRT–PCR. As shown in Figure 6C, Dazap2
down-regulation resulted in the lower stimulation of the
Cyclin D1 and Axin2 genes by Wnt3a than observed in
control shRNA-producing cells. Interestingly, the reduced
level of Dazap2 protein partly relieved the Wnt-mediated
repression of the lipocalin 2 (Lcn2) gene (Figure 6C).
Additionally, we performed qRT–PCR analysis in STF
293 cells transiently transfected with control or Dazap2
siRNA. As described above, STF 293 cells contain a
stably integrated luciferase reporter that is under the con-
trol of eight Tcf/Lef-binding sites. This endogenous repor-
ter, which we named Luciferase (LUC), was activated at
the mRNA level up to 13-fold upon stimulation with
Wnt3a for 16h (Figure 7). In agreement with the reporter
gene assays, Dazap2 knockdown resulted in an approxi-
mately forty percent reduction in transcription of this gene
after treatment with Wnt3a. A similar although less robust
decrease in Wnt-activated expression was observed in sev-
eral other Wnt-signalling target genes including AXIN2,
CYCLIN D1, naked cuticle homologue 1 (NKD1; 53,54)
and tumor necrosis factor receptor superfamily, member
19 [(TNFRSF19), known also as TROY; (55,56) (Figure
7)]. To clarify the possible mechanism behind Dazap2
function we wanted to perform ChIP analysis. Since we
did not succeed to perform ChIP on the promoters of the
Axin2 and Cyclin D1 genes in any mouse or human cells
(including C57MG and STF 293 cells) we extended our
analysis to the TCF-responsive enhancers of the
Luciferase, NKD1 and TROY genes. We did not observe
ChIP using our anti-Dazap2 antibody and furthermore,
we only detected a limited pull-down of the Luciferase
transgene (the most extensively up-regulated gene in the
assay) by the anti-b-catenin antibody. Instead we used our
anti-TCF-4 antibody to immunoprecipitate DNA ele-
ments that spanned the promoter regions of the tested
genes (Figure 7). Interestingly, reduction of Dazap2 low-
ered the binding of TCF-4 to the promoters of these Wnt-
signalling target genes. To verify the ChIP results, two
control experiments were carried out. First, we performed
ChIP with a non-speciﬁc antibody (rabbit anti-EGFP).
Second, we used an anti-TCF-4 antibody in an attempt
to immunoprecipitate irrelevant chromosomal DNA that
concealed the open reading frames of the -ACTIN or
LUC genes. In these experiments we never noted any
eﬀect of the cellular levels of Dazap2 on the quantity of
precipitated DNA (Figure 7 and data not shown). As
Dazap2 knockdown did not alter the amount of TCF-4
and b-catenin in the cell (Figures 5A, 6A and data not
shown) these results imply that the Dazap2/TCF-4 inter-
action might inﬂuence the eﬃciency of TCF-4 binding to
the promoters of the genes regulated by the canonical
Wnt-signalling pathway.
DISCUSSION
In this report we provide evidence for an association
between the nuclear Wnt-signalling pathway eﬀectors,
Tcf/Lef proteins, and a small evolutionary conserved pro-
tein Dazap2. Dazap2 was isolated in a Y2H screen that
utilized the N-terminal part of the TCF-4 factor as
bait. Although the Dazap2-interacting domain in TCF-4
is only partially preserved in other Tcf/Lef proteins,
co-immunoprecipitation assays carried out in mammalian
cells clearly demonstrated that all Tcf/Lef family members
bind to Dazap2 with similar aﬃnities (Figure 4B). We
further delineated a short region in TCF-4 spanning aa
214–228 as the interaction domain essential for Dazap2
binding (Figure 2A). Interestingly, the homologous
region in all Tcfs contains amino acids that are not iden-
tical but display similar biochemical properties (Figure
4A). This might indicate a common structural basis for
the association of Tcf/Lef proteins with Dazap2.
Dazap2 was originally identiﬁed as a transcript
expressed in the mouse inner ear with its expression fur-
ther observed in the embryonic heart and developing and
adult mouse brain (31). This report is in stark contrast to
our ﬁnding that illustrates ubiquitous expression of
Dazap2 mRNA in various mouse tissues (Figure 1C).
Nevertheless, our data are in agreement with northern
blot analyses that indicate broad expression of the
Dazap2 gene in diﬀerent human and mouse tissues and
cell lines (32–34). The most remarkable feature of
Dazap2 is the conservation of its DNA and protein
sequence throughout evolution. The identity between
human and mouse protein orthologues is virtually 100%
(there is only one aa change from 168 aa in total)
(Supplementary Figure 1) and human Dazap2 aligns
well, especially at the C-terminus, with the putative
Dazap2 proteins identiﬁed in the invertebrates Ciona
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Figure 7. Dazap2 knockdown decreases binding of TCF-4 to the pro-
moters of the Wnt-signalling target genes. STF 293 cells were trans-
fected with Dazap2 siRNA #2 (siDazap2) or control siRNA (siCTRL).
After a 2-day expansion the cells were transferred to large culture
dishes and stimulated with either Wnt3a ligand or Wnt3a storage
buﬀer only. After 16 h, the cells were harvested and used for mRNA
isolation and cDNA preparation. Alternatively, the cells were ﬁxed
directly in the dishes and utilized for chromatin immunoprecipitation
(ChIP). The left panel shows the results from qRT–PCR analysis. The
relative abundance of the indicated mRNAs in Wnt3a-stimulated versus
control cells was derived from the average CT values after normalizing
to the levels of -ACTIN cDNA. The right panel shows the ChIP
analysis of chromatin isolated from STF 293 cells transfected with con-
trol or Dazap2 siRNA #2 duplexes. Only results for Wnt3a-stimulated
cells are shown. The diagram represents the relative amounts of the
respective DNA element pulled-down by the indicated antibodies. The
amount of input non-immunoprecipitated DNA (evaluated separately
for each primer set) was arbitrarily set to 100%. Data from one rep-
resentative experiment from two in total are given.
3016 Nucleic Acids Research, 2009,Vol.37, No. 9intestinalis and Tribolium castaneum (Figure 1B). Given
that Dazap2 was identiﬁed as a binding partner of many
cellular proteins (57), the necessity to preserve these inter-
actions might possibly explain the low mutational rate of
the Dazap2 sequence throughout evolution. With respect
to the high sequence homology of Dazap2 in various spe-
cies it is rather striking that Dazap2 mutant mice do not
display any remarkable phenotype and are born and bred
as their wild-type littermates (31). The Dazap2
 /  mice
were generated from ES cells via gene trap technology.
Although we cannot exclude that the modiﬁed Dazap2
locus still produces an intact protein, the insertion site of
the reporter gene just several nucleotides downstream
of the putative translation start site and a complete
absence of Dazap2 mRNA expression indicate that the
mutant animals are really Dazap2 null. There are two
possibilities that might explain an absence of phenotype
in Dazap2
 /  mice. First, the phenotype may be very
subtle and/or the mice have to be challenged in some
way to display any phenotype and second, there is
another Dazap2 homologue in the mouse genome that
can functionally replace the damaged gene. Indeed, a
sequence database search in the mouse genome revealed
a Dazap2 pseudogene localized on chromosome 4 and one
gene similar to Dazap2 on chromosome 13. This Dazap2-
like gene comprises several exons and introns and
encodes a putative 168 aa polypeptide that is highly
homologous to Dazap2 (Supplementary Figure 6).
Therefore, we speculate that these genes are redundant
and Dazap2-like can compensate for the absence of the
Dazap2 gene. Interestingly, we have not been able to
detect the expression of the Dazap2-like product in any
of the cell lines tested (data not shown). Thus, to settle
this matter deﬁnitively, the possible redundancy of these
two genes should be tested directly in the Dazap2
mutant animals. Another noticeable feature of the
Dazap2 protein is its subcellular localization. Several
authors have used confocal or ﬂuorescent microscopy to
visualize ectopically expressed Dazap2 as a wild-type
untagged protein or as a variant fused to diﬀerent tags
(mostly N-terminal EGFP). These authors described the
subcellular distribution of Dazap2 as diﬀuse in the cyto-
plasm and nucleus (32,36), in nuclear puncta (39) or in the
nucleus and cytoplasmic SG bodies (38). These experi-
ments were predominantly performed in HeLa cells.
Interestingly, we noted in HeLa (and Cos-7) cells that
both tagged or untagged Dazap2 principally localizes in
the cytoplasm and partly in the nucleus but this distribu-
tion can diﬀer in a limited fraction of the cells possibly as a
consequence of the cell cycle. Nevertheless, Dazap2 was
eﬃciently translocated to the nuclei (or retained in the
nuclei) in cells expressing TCF-4, thus further conﬁrming
the interaction between Dazap2 and TCF-4 (Figure 3B).
To assess the biological signiﬁcance of the association
between Dazap2 and Tcfs, we ﬁrst ectopically expressed
Dazap2 together with three diﬀerent Tcf/b-catenin-
responsive reporters in various cells. The cells were further
stimulated with puriﬁed Wnt3a ligand and the activities of
the reporters were determined in lysates. Surprisingly, we
never observed changes in the transcriptional activity of
the reporters depending on the increased levels of Dazap2.
Subsequently, we utilized RNAi technology to test the
inﬂuence of Dazap2 knockdown on Wnt-dependent tran-
scription. In cells with reduced levels of Dazap2 mRNA
and protein the activities of the Tcf/b-catenin reporters
were signiﬁcantly decreased and the extent of reduction
correlated well with the ability of each particular siRNA
to down-regulate Dazap2 (Figure 5A and B). The
observed results were not related to the non-speciﬁc ‘oﬀ-
target’ eﬀects of the siRNA duplexes used since control
non-silencing siRNA did not show any impact on the
transcriptional activity of the tested constructs. Addition-
ally, similar eﬀects on Wnt signalling were observed in
cells stably expressing Dazap2 shRNAs (Figure 6C).
Importantly, we also demonstrated by qRT–PCR that
Dazap2 knockdown also negatively inﬂuenced the tran-
scriptional activation of endogenous Wnt-signalling
target genes, although to a lesser extent than observed
for the reporter genes (Figures 6C and 7). There are sev-
eral possibilities that could explain the partial discrepancy
between the results obtained from the reporter gene assays
and the qRT–PCR analysis of endogenous genes. First,
the transcriptional regulation of the reporter genes is less
complex than that of the endogenous promoters and pos-
sibly more dependent on the activity of the Wnt pathway.
Second, in the transient siRNA transfections we noted
fast ‘exhaustion’ of Dazap2 siRNA followed by rapid
return of Dazap2 mRNA and protein to the original
levels (data not shown). This in fact could be responsible
for the less pronounced eﬀects of Dazap2 knockdown
especially in experiments where prolonged treatment
with Dazap2 siRNA was needed (Figure 7). Finally, the
reporters used in the study encode a ‘standard’ luciferase
protein that is quite stable and accumulates in the cells.
This presumably would also explain the diﬀerences
between luminometric measurements and the qRT–PCR
analysis.
A possible explanation for the negative impact of
Dazap2 down-regulation on Wnt-stimulated transcription
is that Dazap2 is a stabilizing component of TCF-4/b-
catenin heterocomplexes (Figure 2C). To evaluate this
possibility we tried to examine whether reduced levels
of Dazap2 could disrupt these complexes. However,
co-immunoprecipitation experiments from shRNA-
producing cells did not reveal any diﬀerence in the
amounts of b-catenin pulled down by TCF-4 in cells
with normal or decreased Dazap2 expression (data not
shown). We also excluded the possibility that Dazap2 is
important for the production or stability of TCF-4 or
b-catenin which could have accounted for the decrease
in transcriptional activation from the reporters as
Dazap2 knockdown did not inﬂuence the expression of
either of these Wnt-signalling eﬀectors (Figures 5A, 6A
and data not shown). The Dazap2 interacting domain in
Tcfs partly overlaps with a region that in vivo is bound
by TLE/Groucho proteins (5,6,8). Therefore, we tested
the hypothesis that Dazap2 binding might block the
association of Tcfs with these co-repressors and would
in turn increase the activating function of the Tcf/Lef tran-
scription factors. We transfected pTOPFLASH into con-
trol siRNA- or Dazap2 siRNA-treated HEK 293 cells
together with Grg4, a mouse TLE/Groucho homologue.
Nucleic Acids Research,2009, Vol.37, No. 9 3017The cells were subsequently stimulated with Wnt3a, har-
vested and reporter activities measured in cell lysates. In a
parallel experiment, control siRNA- or Dazap2 siRNA-
treated cells were lipofected with pTOPFLASH and
cDNA encoding either a negative regulator of Wnt signal-
ling, nemo-like kinase (NLK) alone or in combination
with its upstream activating kinases TAB1 and TAK1.
The TAB/TAK/NLK cascade is a downstream compo-
nent of a negative feed-back loop that is activated by
Wnt signalling (58). Active NLK phosphorylates Tcfs
and importantly, this phosphorylation prevents the bind-
ing of Tcf/b-catenin complexes to DNA and consequently
leads to Tcf ubiquitylation and degradation (59–61).
Interestingly, the NLK phosphorylation sites in Tcfs are
located just proximal to the region indispensable for
Dazap2 binding (59). Intriguingly, Winkel and colleagues
(62) recently reported that Dazap2 (referred to as PRTB)
interacts with TAK1 kinase and enhances its enzymatic
activity. Nevertheless, we did not observe any of the
repressive eﬀects of Grg4 or NLK on Wnt signalling
(using the ectopic or integrated reporter) and thus we
did not notice any enhancement of this repression in
cells with reduced Dazap2 expression. Based on these
observations we excluded the possibility that Dazap2
functions as a blocker of the negative functions of TLE/
Groucho and NLK. Finally, we performed a ChIP exper-
iment utilizing chromatin isolated from STF 293 cells with
DAZAP2 down-regulated. The assay revealed a remark-
able decrease in the association of TCF-4 to the Tcf-
responsive sites in the promoters of Wnt-signalling
target genes (Figure 7). These data imply that the Tcf/
Lef interacting partner Dazap2 can modulate in vivo the
aﬃnity of Tcfs for their recognition motifs. Interestingly,
in mouse mammary gland epithelium C57MG cells,
decreased levels of Dazap2 partly relieved the repression
on the Lcn2 gene mediated by Wnt3a treatment
(Figure 6C). As the repressive eﬀect of active Wnt signal-
ling on Lcn2 does not depend on the direct binding of Tcf/
b-catenin complexes to the Lcn2 promoter (63), this result
suggests that Dazap2 levels might modulate the complex
output of the Wnt-signalling pathway. To prove this
hypothesis, we tested the expression of genes that
respond diﬀerentially to the Wnt signal in C57MG
cells, Stromelysin-1 (Sl-1/Mmp3) and mesothelin (Msln)
(64). However, qRT–PCR analysis revealed that the
transcription of these two genes depends on the plat-
ing density of cells in culture rather than speciﬁcally on
Wnt signalling (P.M. and V.K., unpublished data).
Nevertheless, preliminary cDNA microarray data
obtained from mRNAs isolated from Wnt-stimulated
C57MG cells expressing Dazap2-speciﬁc or control
shRNAs indicate that indeed, both the activating and
also the inhibitory function of Tcf/Lef proteins might be
inﬂuenced by the amounts of Dazap2 (P.M., R.I. and
V.K., unpublished data).
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Supplementary Data are available at NAR Online.
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